Timothy S Blackwell Selected Research

Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)

1/2022	Secretory Cells Are the Primary Source of pIgR in Small Airways.
11/2018	Lung Dendritic Cells Drive Natural Killer Cytotoxicity in Chronic Obstructive Pulmonary Disease via IL-15Rα.
1/2018	Bacterial-derived Neutrophilic Inflammation Drives Lung Remodeling in a Mouse Model of Chronic Obstructive Pulmonary Disease.
4/2016	Airway bacteria drive a progressive COPD-like phenotype in mice with polymeric immunoglobulin receptor deficiency.
8/2011	Bronchial secretory immunoglobulin a deficiency correlates with airway inflammation and progression of chronic obstructive pulmonary disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Timothy S Blackwell Research Topics

Disease

58	Inflammation (Inflammations) 01/2022 - 06/2005
33	Pneumonia (Pneumonitis) 01/2021 - 03/2002
30	Neoplasms (Cancer) 01/2022 - 02/2006
26	Fibrosis (Cirrhosis) 01/2022 - 10/2004
16	Lung Injury 01/2018 - 11/2003
13	Carcinogenesis 01/2022 - 03/2007
12	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 10/2004
11	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 08/2011
10	Idiopathic Pulmonary Fibrosis 01/2021 - 01/2008
10	Infections 09/2014 - 11/2003
9	Lung Neoplasms (Lung Cancer) 11/2020 - 05/2007
7	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2018 - 01/2011
6	Lung Diseases (Lung Disease) 01/2022 - 01/2003
6	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2008
6	Hypoxia (Hypoxemia) 12/2018 - 05/2007
6	Asthma (Bronchial Asthma) 01/2016 - 12/2009
6	Chronic Granulomatous Disease 04/2013 - 03/2010
5	Emphysema 01/2021 - 02/2016
5	Mycoses (Diseases, Fungus) 04/2013 - 03/2010
5	Hyperplasia 12/2011 - 12/2009
5	Malignant Pleural Effusion 11/2010 - 02/2006
4	Adenocarcinoma of Lung 01/2022 - 03/2008
4	Adenocarcinoma 06/2015 - 01/2008
4	Bacterial Infections (Bacterial Infection) 09/2014 - 02/2008
4	Acute Lung Injury 02/2013 - 04/2006
3	Disease Progression 01/2022 - 01/2016
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 11/2007
3	Lewis Lung Carcinoma 12/2019 - 03/2008
3	Pulmonary Hypertension 12/2018 - 06/2012
3	Airway Remodeling 01/2018 - 04/2012
3	Atherosclerosis 01/2017 - 10/2006
3	Hypertension (High Blood Pressure) 02/2014 - 10/2006
3	Sepsis (Septicemia) 01/2013 - 02/2004
3	Pleural Effusion (Pleural Effusions) 02/2007 - 06/2005
3	Pancreatitis 10/2006 - 03/2003
2	COVID-19 01/2021 - 08/2020
2	Hyperoxia 01/2020 - 02/2006
2	Insulin Resistance 11/2015 - 09/2009
2	Colonic Neoplasms (Colon Cancer) 06/2015 - 04/2015

Drug/Important Bio-Agent (IBA)

30	NF-kappa B (NF-kB)IBA 01/2020 - 05/2002
24	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 10/2004
20	CytokinesIBA 12/2021 - 05/2002
16	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2004
12	CollagenIBA 12/2021 - 01/2005
10	NADPH Oxidases (NAD(P)H oxidase)IBA 09/2013 - 02/2004
9	Urethane (Ethyl Carbamate)IBA 12/2019 - 11/2007
9	LipopolysaccharidesIBA 12/2017 - 06/2002
8	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 10/2006
8	Transcription Factors (Transcription Factor)IBA 01/2020 - 05/2007
8	Surface-Active Agents (Surfactants)IBA 01/2018 - 11/2005
7	LigandsIBA 01/2022 - 10/2004
7	Secretory Immunoglobulin A (SIgA)IBA 01/2022 - 08/2011
6	RNA (Ribonucleic Acid)IBA 01/2022 - 12/2018
6	Phosphotransferases (Kinase)IBA 01/2018 - 01/2003
6	Protein CIBA 01/2018 - 11/2005
6	EndotoxinsIBA 06/2012 - 05/2002
5	CarcinogensIBA 01/2022 - 04/2012
5	Polymeric Immunoglobulin Receptors (Polymeric Immunoglobulin Receptor)IBA 01/2022 - 08/2011
5	CateninsIBA 01/2020 - 03/2013
5	ChemokinesIBA 01/2019 - 10/2004
5	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019 - 06/2011
5	Doxycycline (Periostat)FDA LinkGeneric 01/2018 - 05/2007
5	AntioxidantsIBA 01/2017 - 01/2009
5	Oxidants (Oxidizing Agents)IBA 01/2016 - 03/2010
5	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 05/2015 - 03/2010
5	I-kappa B KinaseIBA 09/2009 - 01/2003
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2018 - 06/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 02/2007
4	Interleukin-5 (Interleukin 5)IBA 04/2015 - 06/2005
4	OvalbuminIBA 09/2014 - 08/2010
4	LuciferasesIBA 09/2012 - 03/2003
3	IntegrinsIBA 01/2022 - 01/2020
3	ProstaglandinsIBA 01/2022 - 06/2005
3	Interleukin-17 (Interleukin 17)IBA 01/2019 - 09/2014
3	Biological ProductsIBA 12/2018 - 04/2015
3	InterleukinsIBA 01/2018 - 06/2005
3	EnzymesIBA 01/2018 - 01/2011
3	Bortezomib (Velcade)FDA Link 01/2016 - 03/2010
3	MicroRNAs (MicroRNA)IBA 01/2016 - 01/2011
3	Clodronic Acid (Clodronate)IBA 12/2014 - 05/2002
3	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 12/2013 - 08/2007
3	AllergensIBA 07/2013 - 12/2009
3	ZymosanIBA 04/2013 - 03/2010
3	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 04/2012 - 10/2006
2	Arachidonic Acid (Vitamin F)IBA 01/2022 - 01/2016
2	Immunoglobulin A (IgA)IBA 01/2022 - 12/2015
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 08/2020
2	Long Noncoding RNAIBA 01/2021 - 01/2019
2	ElastinIBA 01/2021 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2021 - 03/2010
2	SmokeIBA 11/2018 - 01/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2018 - 10/2010
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2018 - 04/2012
2	AntibodiesIBA 01/2018 - 12/2015
2	cyclopentenoneIBA 01/2017 - 10/2005
2	Tetracycline (Achromycin)FDA LinkGeneric 02/2016 - 08/2011
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2016 - 08/2007
2	telomerase RNA (bTR)IBA 01/2016 - 04/2012
2	Oncogene Proteins (Oncogene Protein)IBA 09/2015 - 03/2007

Therapy/Procedure

16	Therapeutics 01/2022 - 01/2003